vialroom

#retatrutide 2025-03-15

Saturday28 messages8 participantstimes are UTC
Highlights from this day
  • per_mg_pete — the phase 2 weight result was larger than what the earlier agonists reported, in a smaller shorter trial 09:01
  • impersonator_ip — triple agonist, GLP-1 and GIP and glucagon. the glucagon arm is the part with no long history, thats one data point 10:08
  • u100_pat — how do people square the research use only framing with logging their own use 12:33
  • mag_citrate — energy expenditure isnt something i could feel, though my sleep tracker disagreed with me 14:04

the phase 2 weight result was larger than what the earlier agonists reported, in a smaller shorter trial

🤝1📈17

is TRIUMPH the phase 3 programme

blood pressure stayed flat for me while heart rate moved, which i didnt expect

II

appetite suppression at 0.25 was stronger than my tirzepatide experience at a comparable point

VV

VendorInvestigate came back 98.1 on one lot and 99.4 on the next from the same TFC, both fine, n of 1 obviously

quick one phase 2 was still trending at the end which is why the phase 3 readout matters more than usual

watching my heart rate

U1

there is no long term safety data, phase 2 and an ongoing phase 3 programme is what exists, i think

U1

how do people square the research use only framing with logging their own use

🔥10💀11👍10
U1

is the glucagon arm what people mean by the energy expenditure thing

12:48tenpence pinned a message
U1

is there any long term safety data at all or is it phase 2 and hope

low and slow

TE

came off at 24 weeks because my resting rate stayed elevated and i didnt like it

VB

Reminder for mag_citrate: dose day is today. Set 8 days ago.

logging rhr daily

MC

energy expenditure isnt something i could feel, though my sleep tracker disagreed with me

baseline  58
wk 2      61
wk 4      64
wk 6      67
wk 8      66
wk 10     65   (held dose from wk 7)
😂16🧊6